The potential role of TNFα in 2019 novel coronavirus pneumonia

The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitis (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.

Detalles Bibliográficos
Autores principales: Ye, Wenjing, Lu, Saisai, xue, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215148/
https://www.ncbi.nlm.nih.gov/pubmed/32399393
http://dx.doi.org/10.1016/j.rmcr.2020.101087
Descripción
Sumario:The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitis (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.

Ejemplares similares